These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1857216)

  • 1. Derivation of monoclonal antibody to basic fibroblast growth factor and its application.
    Yoshitake Y; Matsuzaki K; Nishikawa K
    Methods Enzymol; 1991; 198():148-57. PubMed ID: 1857216
    [No Abstract]   [Full Text] [Related]  

  • 2. Generation of antibodies and assays for transforming growth factor beta.
    Lucas C; Fendly BM; Mukku VR; Wong WL; Palladino MA
    Methods Enzymol; 1991; 198():303-16. PubMed ID: 1857224
    [No Abstract]   [Full Text] [Related]  

  • 3. Localization of peptide growth factors in the nucleus.
    Gabriel B; Baldin V; Roman AM; Bosc-Bierne I; Noaillac-Depeyre J; Prats H; Teissié J; Bouche G; Amalric F
    Methods Enzymol; 1991; 198():480-94. PubMed ID: 1857237
    [No Abstract]   [Full Text] [Related]  

  • 4. Labeling of basic fibroblast growth factor with digoxigenin: a nonradioactive probe for biochemical and cytological applications.
    Gleizes PE; Noaillac-Depeyre J; Gas N
    Anal Biochem; 1994 Jun; 219(2):360-7. PubMed ID: 8080093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning, recombinant expression, and characterization of basic fibroblast growth factor.
    Thompson SA; Protter AA; Bitting L; Fiddes JC; Abraham JA
    Methods Enzymol; 1991; 198():96-116. PubMed ID: 1857242
    [No Abstract]   [Full Text] [Related]  

  • 6. Localization of basic fibroblast growth factor (bFGF) in a metastatic cell line (AT-3) established from the Dunning prostatic carcinoma of rat: application of a specific monoclonal antibody.
    Nishikawa K; Yoshitake Y; Minemura M; Yamada K; Matuo Y
    Adv Exp Med Biol; 1992; 324():131-9. PubMed ID: 1283495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of fibroblast growth factor-related transforming gene hst-1.
    Yoshida T; Miyagawa K; Sakamoto H; Sugimura T; Terada M
    Methods Enzymol; 1991; 198():124-38. PubMed ID: 1830360
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of a novel immune complex to isolate neutralizing antibodies to basic fibroblast growth factor.
    Songsakphisarn R; Goldstein N
    Hybridoma; 1993 Jun; 12(3):343-8. PubMed ID: 8359827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intraperitoneally, intravenously and intralesionally administered monoclonal anti-beta-FGF antibodies on rat chondrosarcoma tumor vascularization and growth.
    Coppola G; Atlas-White M; Katsahambas S; Bertolini J; Hearn MT; Underwood JR
    Anticancer Res; 1997; 17(3C):2033-9. PubMed ID: 9216661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation and identification of phosphorylated forms of basic fibroblast growth factor.
    Feige JJ; Baird A
    Methods Enzymol; 1991; 198():138-47. PubMed ID: 1857215
    [No Abstract]   [Full Text] [Related]  

  • 11. Different antitumor activities of anti-bFGF neutralizing antibodies: heparin-binding domain provides an inefficient epitope for neutralization in vivo.
    Aonuma M; Yoshitake Y; Nishikawa K; Tanaka NG
    Anticancer Res; 1999; 19(5B):4039-44. PubMed ID: 10628351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies directed against basic fibroblast growth factor which inhibit its biological activity in vitro and in vivo.
    Reilly TM; Taylor DS; Herblin WF; Thoolen MJ; Chiu AT; Watson DW; Timmermans PB
    Biochem Biophys Res Commun; 1989 Oct; 164(2):736-43. PubMed ID: 2479375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of basic fibroblast growth factor in porcine thyroids.
    Emoto N; Isozaki O; Arai M; Murakami H; Shizume K; Baird A; Tsushima T; Demura H
    Endocrinology; 1991 Jan; 128(1):58-64. PubMed ID: 1702706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of cell surface-associated basic fibroblast growth factor by glycosylphosphatidylinositol-specific phospholipase C.
    Bashkin P; Neufeld G; Gitay-Goren H; Vlodavsky I
    J Cell Physiol; 1992 Apr; 151(1):126-37. PubMed ID: 1313817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of biological activity of synthetic fragments of transforming growth factor alpha.
    Schultz G; Twardzik D
    Methods Enzymol; 1991; 198():200-13. PubMed ID: 1857219
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibroblast growth factor-like autoantibodies in plasma from patients with multiple endocrine neoplasia type 1 and prolactinoma.
    Zimering MB; Katsumata N; Friesen HG; Eng J; Riley DJ; Thakker-Varia S; Marx SJ; Ezzat S
    Ann N Y Acad Sci; 1997 Apr; 815():520-3. PubMed ID: 9186715
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis.
    Matsuzaki K; Yoshitake Y; Matuo Y; Sasaki H; Nishikawa K
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9911-5. PubMed ID: 2481318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic fibroblast growth factor in human prostate cancer cells.
    Nakamoto T; Chang CS; Li AK; Chodak GW
    Cancer Res; 1992 Feb; 52(3):571-7. PubMed ID: 1732045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of modulation of basic fibroblast growth factor on tumor growth in vivo.
    Gross JL; Herblin WF; Dusak BA; Czerniak P; Diamond MD; Sun T; Eidsvoog K; Dexter DL; Yayon A
    J Natl Cancer Inst; 1993 Jan; 85(2):121-31. PubMed ID: 8418301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biaffinity chromatography of fibroblast growth factors.
    Shing Y
    Methods Enzymol; 1991; 198():91-5. PubMed ID: 1857241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.